MedTrace Logo

The Effect of Riboflavin in Crohn's Disease

NCT02538354 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-04-03

Study results available
· View outcomes & findings →

Summary

This study will evaluate if suppelementation of the diet with riboflavin in Crohn's disease patients will result in an increase in the amount of F. prausnitzii.

Conditions

  • Crohn Disease

Interventions

DIETARY_SUPPLEMENT

Riboflavin supplementation

Supplementation of the normal diet with 1 capsule of 100 mg riboflavin (vitamin B2) during three weeks

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02538354 on ClinicalTrials.gov